Electrosprayed genipin cross‐linked alginate–chitosan microcarriers for ex vivo expansion of mesenchymal stem cells

Autor: Chui, CY, Odeleye, A, Nguyen, L, Kasoju, N, Soliman, E, Ye, H

Mesenchymal stem cells (MSCs) are potential therapeutic candidates, owing to their ability to differentiate into several cell types. However, the gap between availability and demand of MSCs requires alternative expansion methods from 2D culture flask

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1019d5f9ea91b3e60722cdcb3a9698f3
https://doi.org/10.1002/jbm.a.36539

SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-β signaling.

Autor: Biering SB; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA., de Sousa FTG; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA., Tjang LV; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA., Pahmeier F; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA., Ruan R; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA., Blanc SF; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA., Patel TS; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA., Worthington CM; Chan Zuckerberg Biohub, San Francisco, CA, USA., Glasner DR; Department of Laboratory Medicine, University of California, San Francisco, CA, USA.; UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA., Castillo-Rojas B; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA., Servellita V; Department of Laboratory Medicine, University of California, San Francisco, CA, USA.; UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA., Lo NTN; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA., Wong MP; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA., Warnes CM; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA., Sandoval DR; Department of Cellular and Molecular Medicine, Glycobiology Research and Training Center, University of California, San Diego, La Jolla, CA, USA., Clausen TM; Department of Cellular and Molecular Medicine, Glycobiology Research and Training Center, University of California, San Diego, La Jolla, CA, USA., Santos YA; Department of Laboratory Medicine, University of California, San Francisco, CA, USA.; UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA., Ortega V; Department of Microbiology and Immunology, Cornell University, Ithaca, NY, USA., Aguilar HC; Department of Microbiology and Immunology, Cornell University, Ithaca, NY, USA., Esko JD; Department of Cellular and Molecular Medicine, Glycobiology Research and Training Center, University of California, San Diego, La Jolla, CA, USA., Chui CY; Department of Laboratory Medicine, University of California, San Francisco, CA, USA.; UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA.; Innovative Genomics Institute, University of California, Berkeley, CA, USA.; Department of Medicine, University of California, San Francisco, CA, USA., Pak JE; Chan Zuckerberg Biohub, San Francisco, CA, USA., Beatty PR; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA., Harris E; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA.; Lead contact.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2021 Dec 13. Date of Electronic Publication: 2021 Dec 13.

Prevalence and recognition of highly significant medication-smoking cessation interactions in a smoke-free hospital.

Autor: Chui CY; Centre for Medicine Use and Safety, Monash University, 381 Royal Parade, Parkville, VIC 3052, Australia; Department of Pharmaceutical Sciences, University of Utrecht, Universiteitsweg 99, 3584 CG Utrecht, the Netherlands; Pharmacy Department, Haaglanden Medisch Centrum, Lijnbaan 32, 2512 VA Den Haag, the Netherlands., Taylor SE; Pharmacy Department, Austin Health, 145 Studley Road, Heidelberg, VIC 3084, Australia. Electronic address: simone.taylor@austin.org.au., Thomas D; Centre for Medicine Use and Safety, Monash University, 381 Royal Parade, Parkville, VIC 3052, Australia; National Drug and Alcohol Research Centre, University of New South Wales, 22-32 King St, Randwick, NSW 2031, Australia., George J; Centre for Medicine Use and Safety, Monash University, 381 Royal Parade, Parkville, VIC 3052, Australia.

Publikováno v: Drug and alcohol dependence [Drug Alcohol Depend] 2019 Jul 01; Vol. 200, pp. 78-81. Date of Electronic Publication: 2019 Apr 25.

Development of thermo-responsive polycaprolactone macrocarriers conjugated with Poly(N-isopropyl acrylamide) for cell culture.

Autor: Nguyen LTB; Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, OX3 7DQ, UK., Odeleye AOO; Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, OX3 7DQ, UK.; Adaptimmune Limited, 60 Jubilee Avenue, Milton Park, Abingdon, OX14 4RX, UK., Chui CY; Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, OX3 7DQ, UK., Baudequin T; Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, OX3 7DQ, UK., Cui Z; Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, OX3 7DQ, UK., Ye H; Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, OX3 7DQ, UK. hua.ye@eng.ox.ac.uk.

Publikováno v: Scientific reports [Sci Rep] 2019 Mar 05; Vol. 9 (1), pp. 3477. Date of Electronic Publication: 2019 Mar 05.

Factors associated with nicotine replacement therapy use among hospitalised smokers.

Autor: Chui CY; Centre for Medicine Use and Safety, Monash University, Melbourne, Australia.; Department of Pharmaceutical Sciences, University of Utrecht, Utrecht, The Netherlands., Thomas D; Centre for Medicine Use and Safety, Monash University, Melbourne, Australia., Taylor S; Pharmacy Department, Austin Health, Melbourne, Australia., Bonevski B; School of Medicine and Public Health, University of Newcastle, Newcastle, Australia., Abramson MJ; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Paul E; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.; Clinical Haematology Department, The Alfred, Melbourne, Australia., Poole SG; Centre for Medicine Use and Safety, Monash University, Melbourne, Australia.; Pharmacy Department, Alfred Health, Melbourne, Australia., Weeks GR; Centre for Medicine Use and Safety, Monash University, Melbourne, Australia.; Pharmacy Department, Barwon Health, Geelong, Australia., Dooley MJ; Centre for Medicine Use and Safety, Monash University, Melbourne, Australia.; Pharmacy Department, Alfred Health, Melbourne, Australia., George J; Centre for Medicine Use and Safety, Monash University, Melbourne, Australia.

Publikováno v: Drug and alcohol review [Drug Alcohol Rev] 2018 May; Vol. 37 (4), pp. 514-519. Date of Electronic Publication: 2018 Feb 07.